Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nxera Pharma shares continue to rise on milestone achievement in drug discovery partnership with AbbVie
Nxera Pharma hits third milestone in AbbVie neuroscience collaboration
Nxera Pharma Hits New Year-to-Date High on Second Development Milestone Achievement in Eli Lilly Partnership
Active Stocks (Close): SAMCO, REFINVERSE Group, Nxera Pharma and others
Nxera Pharma surges again, briefly hitting daily limit as partner Centessa to be acquired by Eli Lilly
Nxera Pharma, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
Nxera Pharma, Jan-Sep (Cumulative 3Q) Net Income Loss Widens, Jul-Sep Net Income Turns to Loss
Nxera Pharma, Apr-Jun (2Q) Net Income Loss Widens
Nxera Pharma, Jan-Mar (1Q) Net Income Loss Narrows
Nxera Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
Nxera Pharma Co., Ltd., January-September (Third Quarter Cumulative) Net Income Loss Narrows, July-September Net Income Turns to Profit